Comorbid Depression in Patients With Head and Neck Cancer Compared With Other Cancers

Area of Science:

• Oncology
• Psychiatry
• Epidemiology

Background:

• Depression is more common in cancer patients and linked to higher mortality, especially in head and neck cancer (HNC).
• Understanding depression prevalence differences between HNC and other cancer types is crucial for targeted interventions.

Purpose of the Study:

• To compare the prevalence and severity of depression in patients with head and neck cancer versus those with other cancer types.
• To identify factors associated with depression in cancer patients.

Main Methods:

• Retrospective cohort study using 2019 National Health Interview Survey data.
• Analysis included adult cancer patients who completed the Personal Health Questionnaire-8 (PHQ-8).
• Multivariable logistic regression was used to assess associations with depression.

Main Results:

• The prevalence of depression was 40.1% in HNC patients versus 22.3% in other cancer patients.
• HNC patients were twice as likely to screen positive for depression (OR, 2.94).
• Anxiety and being unmarried were strongly associated with depression.

Conclusions:

• Patients with HNC exhibit a higher depression screening rate than those with other cancers.
• Self-reporting may lead to underdiagnosis and undertreatment of depression in HNC.
• Enhanced identification and treatment strategies are needed for HNC patients with comorbid depression.